logoCabeceraNinos

Hemos leído sobre ... Uveítis

Última actualización:  22 agosto 2017


 
JUNIO 2017
  • Rosenbaum JT.
    New developments in uveitis associated with HLA B27.
    Curr Opin Rheumatol. 2017 Jul;29(4):298-303.
    https://www.ncbi.nlm.nih.gov/pubmed/28376061
  • Simonini G, Bracaglia C, Cattalini M, Taddio A, Brambilla A, De Libero C, Pires Marafon D, Caputo R, Cimaz R.
    Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis.
    J Rheumatol. 2017 Jun;44(6):822-826.
    https://www.ncbi.nlm.nih.gov/pubmed/28365583
  • Muñoz-Gallego A, Barral E, Enríquez E, Tejada P, Barceló A, de Inocencio J.
    Adalimumab for the treatment of refractory noninfectious paediatric uveitis.
    Int Ophthalmol. 2017 Jun;37(3):719-725.
    https://www.ncbi.nlm.nih.gov/pubmed/27432171
 
MAYO 2017
  • Lopalco G, Fabiani C, Sota J, Lucherini OM, Tosi GM, Frediani B, Iannone F, Galeazzi M, Franceschini R, Rigante D, Cantarini L.
    IL-6 blockade in the management of non-infectious uveitis.
    Clin Rheumatol. 2017 May 20. [Epub ahead of print]
 
ABRIL 2017
  • Berker N, Sen E, Elgin U, Atilgan CU, Dursun E, Yilmazbas P.
    Analysis of clinical features and visual outcomes of pars planitis
    Int Ophthalmol. 2017 Apr 7. doi: 10.1007/s10792-017-0526-2. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/28389773
MARZO 2017
  • Simonini G, Bracaglia C, Cattalini M, Taddio A, Brambilla A, De Libero C, Pires Marafon D, Caputo R, Cimaz R.
    Predictors of Relapse after Discontinuing Systemic Treatment in Childhood Autoimmune Chronic Uveitis.
    J Rheumatol. 2017 Apr 1. pii: jrheum.161336. doi: 10.3899/jrheum.161336. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/28365583
  • Rosenbaum JT.
    New developments in uveitis associated with HLA B27.
    Curr Opin Rheumatol. 2017 Apr 3. doi: 10.1097/BOR.0000000000000403. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/28376061

FEBRERO 2017
  • Haasnoot AJ, Sint Jago NF, Tekstra J, de Boer JH1.
    Impact of uveitis on Quality of Life in Adult patients with Juvenile Idiopathic Arthritis.
    Arthritis Care Res (Hoboken). 2017 Feb 19. doi: 10.1002/acr.23224. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/28217950
  • Papadopoulou M, Zetterberg M,, Oskarsdottir S, Andersson Grönlund M.
    Assessment of the outcome of ophthalmological screening for uveitis in a cohort of Swedish children with juvenile idiopathic arthritis.
    Acta Ophthalmol. 2017 Feb 15. doi: 10.1111/aos.13388. [Epub ahead of print]
    https://www.ncbi.nlm.nih.gov/pubmed/28205413
  • Quesada-Masachs E, Caballero CM.
    Subcutaneous Tocilizumab May Be Less Effective than Intravenous Tocilizumab in the Treatment of Juvenile Idiopathic Arthritis-associated Uveitis.
    J Rheumatol. 2017 Feb;44(2):260-261. doi: 10.3899/jrheum.160908.
    https://www.ncbi.nlm.nih.gov/pubmed/28148759
  • Kahwage PP, Ferriani MP, Furtado JM, de Carvalho LM, Pileggi GS, Gomes FH, Terreri MT, Magalhães CS, Pereira RM, Sacchetti SB, Marini R, Bonfá E, Silva CA, Ferriani VP.
    Uveitis in childhood-onset systemic lupus erythematosus patients: a multicenter survey.
    Clin Rheumatol. 2017 Mar;36(3):547-553. doi: 10.1007/s10067-016-3534-0. Epub 2017 Jan 9.
    https://www.ncbi.nlm.nih.gov/pubmed/28070763

ENERO 2017
 
DICIEMBRE 2016
  • Tappeiner C, Mesquida M, Adán A, Anton J, Ramanan AV, Carreno E, Mackensen F, Kotaniemi K, de Boer JH, Bou R, de Vicuña CG, Heiligenhaus A.
    Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.
    J Rheumatol. 2016 Dec;43(12):2183-2188.
    https://www.ncbi.nlm.nih.gov/pubmed/27633821

NOVIEMBRE 2016
  • Pato E, Martin-Martinez MA, Castelló A, Méndez-Fernandez R, Muñoz-Fernández S, Cordero-Coma M, Martinez-Costa L, Valls E, Reyes M, Francisco F, Esteban M, Fonollosa A, Sanchez-Alonso F, Fernández-Espartero C, Diaz-Valle T, Carrasco JM, Beltran-Catalán E, Hernández-Garfella M, Hernández MV, Pelegrin L, Blanco R, Diaz-Valle D.
    Development of an activity disease score in patients with uveitis (UVEDAI).
    Rheumatol Int. 2016 Nov 4.
    https://www.ncbi.nlm.nih.gov/pubmed/27815703
  • Birolo C, Zannin ME, Arsenyeva S, Cimaz R, Miserocchi E, Dubko M, Deslandre CJ, Falcini F, Alessio M, La Torre F, Denisova E, Martini G, Nikishina I, Zulian F.
    Comparable Efficacy of Abatacept Used as First-line or Second-line Biological Agent for Severe Juvenile Idiopathic Arthritis-related Uveitis.
    J Rheumatol. 2016 Nov;43(11):2068-2073.
    https://www.ncbi.nlm.nih.gov/pubmed/27633826

SEPTIEMBRE 2016
  • Breitbach M, Tappeiner C, Böhm MR, Zurek-Imhoff B, Heinz C, Thanos S, Ganser G, Heiligenhaus A.
    Discontinuation of long-term adalimumab treatment in patients with juvenile idiopathic arthritis-associated uveitis.
    Graefes Arch Clin Exp Ophthalmol. 2016 Sep 30.
    https://www.ncbi.nlm.nih.gov/pubmed/27687987
  • Balevic SJ, Rabinovich CE.
    Drug Des Devel Ther. 2016 Sep 19;10:2997-3003.
    Profile of adalimumab and its potential in the treatment of uveitis.
    https://www.ncbi.nlm.nih.gov/pubmed/27698552
  • Haasnoot AJ, Vernie LA, Rothova A, V D Doe P, Los LI, Schalij-Delfos NE, de Boer JH.
    Impact of Juvenile Idiopathic Arthritis Associated Uveitis in Early Adulthood.
    PLoS One. 2016 Oct 10;11(10):e0164312.
    https://www.ncbi.nlm.nih.gov/pubmed/27723840
  • Calvo-Río V, Santos-Gómez M, Calvo I, González-Fernández MI, López Montesinos B, Mesquida M, Adán A, Victoria Hernández M, Maíz O, Atanes A, Bravo B, Modesto C, Díaz-Cordovés G, Palmou-Fontana N, Loricera J, González-Vela MC, Demetrio-Pablo R, Hernández JL, González-Gay MA, Blanco R.
    Anti-IL6-R Tocilizumab for Severe Juvenile Idiopathic Arthritis-Associated Uveitis Refractory to anti-TNF therapy. A multicenter study of 25 patients.
    Arthritis Rheumatol. 2016 Oct 1.
    https://www.ncbi.nlm.nih.gov/pubmed/27696756
  • Böhm MR, Tappeiner C, Breitbach MA, Zurek-Imhoff B, Heinz C, Heiligenhaus A.
    Ocular hypotony in patients with juvenile idiopathic arthritis - associated uveitis.
    Am J Ophthalmol. 2016 Sep 21.
    https://www.ncbi.nlm.nih.gov/pubmed/27664701
  • Tappeiner C, Mesquida M, Adán A, Anton J, Ramanan AV, Carreno E, Mackensen F, Kotaniemi K, de Boer JH, Bou R, de Vicuña CG, Heiligenhaus A.
    Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.
    J Rheumatol. 2016 Sep 15.
    https://www.ncbi.nlm.nih.gov/pubmed/27633821
  • Moradi A, Stroh IG, Reddy AK, Hornbeak DM, Leung TG, Burkholder BM, Thorne JE.
    Risk of Hypotony in Juvenile Idiopathic Arthritis-Associated Uveitis.
    Am J Ophthalmol. 2016 Sep;169:113-24.
    https://www.ncbi.nlm.nih.gov/pubmed/27345732

AGOSTO 2016
  • Tappeiner C, Mesquida M, Adán A, Anton J, Ramanan AV, Carreno E, Mackensen F, Kotaniemi K, de Boer JH, Bou R, de Vicuña CG, Heiligenhaus A.
    Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.
    J Rheumatol. 2016 Sep 15. pii: jrheum.160231. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27633821
  • Birolo C, Zannin ME, Arsenyeva S, Cimaz R, Miserocchi E, Dubko M, Deslandre CJ, Falcini F, Alessio M, La Torre F, Denisova E, Martini G, Nikishina I, Zulian F.
    Comparable Efficacy of Abatacept Used as First-line or Second-line Biological Agent for Severe Juvenile Idiopathic Arthritis-related Uveitis.
    J Rheumatol. 2016 Sep 15. pii: jrheum.151389. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27633826
  • Guindolet D, Dureau P, Terrada C, Edelson C, Barjol A, Caputo G, LeHoang P, Bodaghi B.
    Cataract Surgery with Primary Lens Implantation in Children with Chronic Uveitis.
    Ocul Immunol Inflamm. 2016 Sep 6:1-7. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27599095   
  • Paovic J, Paovic P, Sredovic V, Jovanovic S
    Clinical Manifestations, Complications and Treatment of Ocular Sarcoidosis: Correlation between Visual Efficiency and Macular Edema as Seen on Optical Coherence Tomography.
    Semin Ophthalmol. 2016 Sep 14:1-8. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27628176

JULIO 2016
  • Haasnoot AM, Kuiper JJ, Hiddingh S, Schellekens PA, de Jager W, Imhof SM, Radstake TR, de Boer JH.
    Ocular Fluid Analysis in Children Reveals Interleukin-29/Interferon-λ1 as a Biomarker for Juvenile Idiopathic Arthritis-Associated Uveitis.
    Arthritis Rheumatol. 2016 Jul;68(7):1769-79. doi: 10.1002/art.39621.
    http://www.ncbi.nlm.nih.gov/pubmed/26866822
  • Muñoz-Gallego A, Barral E, Enríquez E, Tejada P, Barceló A, de Inocencio J
    Adalimumab for the treatment of refractory noninfectious paediatric uveitis.
    Int Ophthalmol. 2016 Jul 18. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27432171 
  • Kostik MM, Gaidar EV, Hynnes AY, Dubko MF, Masalova VV, Snegireva LS, Chikova IA, Isupova EA, Nikitina TN, Serogodskaya ED, Kalashnikova OV, Ravelli A, Chasnyk VG.
    Methotrexate treatment may prevent uveitis onset in patients with juvenile idiopathic arthritis: experiences and subgroup analysis in a cohort with frequent methotrexate use.
    Clin Exp Rheumatol. 2016 Jul-Aug;34(4):714-8. Epub 2016 Jun 22.
    http://www.ncbi.nlm.nih.gov/pubmed/27385618

JUNIO 2016

MAYO 2016

ABRIL 2016

MARZO 2016
  • Vallet H, Seve P, Biard L, Baptiste Fraison J, Bielefeld P, Perard L, et al; french uveitis network.
    Infliximab versus adalimumab in the treatment of refractory inflammatory uveitis: Multicenter study from the french uveitis network.
    Arthritis Rheumatol. 2016 Mar 25. doi: 10.1002/art.39667. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27015607
  • Silpa-Archa S, Oray M, Preble JM, Foster CS.
    Outcome of tocilizumab treatment in refractory ocular inflammatory diseases.
    Acta Ophthalmol. 2016 Mar 24. doi: 10.1111/aos.13015. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27010181
  • Stroh IG, Moradi A, Burkholder BM, Hornbeak DM, Leung TG, Thorne JE.
    Occurrence of and Risk Factors for Ocular Hypertension and Secondary Glaucoma inJuvenile Idiopathic Arthritis-associated Uveitis.
    Ocul Immunol Inflamm. 2016 Mar 22:1-10. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27003850
  • Verhagen FH, Brouwer AH, Kuiper JJ, Ossewaarde-van Norel J, Ten Dam-van Loon NH, de Boer JH.
    Potential Predictors of Poor Visual Outcome in Human Leukocyte Antigen-B27-Associated Uveitis.
    Am J Ophthalmol. 2016 Mar 3. pii: S0002-9394(16)30074-5. doi: 10.1016/j.ajo.2016.02.024. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26940162
  • Yeo TH, Ilangovan S, Keane PA, Pavesio C, Agrawal R.
    Discrepancies in assessing anterior chamber activity among uveitis specialists.
    Jpn J Ophthalmol. 2016 Mar 28. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27020454
  • Rosenbaum JT, Lin P, Asquith M.
    Does the Microbiome Cause B27-related Acute Anterior Uveitis?
    Ocul Immunol Inflamm. 2016 Mar 22:1-5. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27002532
  • Phatak S, Lowder C, Pavesio C.
    Controversies in intraocular lens implantation in pediatric uveitis.
    J Ophthalmic Inflamm Infect. 2016 Dec;6(1):12. doi: 10.1186/s12348-016-0079-
    http://www.ncbi.nlm.nih.gov/pubmed/27009616
  • Abásolo L, Prieto-García Á, Díaz-Valle D, Benítez-Del-Castillo JM, Pato E, García-Feijoo J, Fernández-Gutiérrez B, Rodriguez-Rodriguez L
    Influence of baseline demographic and clinical characteristics in the visual outcome of intermediate uveitis: a survival analysis.
    Br J Ophthalmol. 2016 Mar 30. pii: bjophthalmol-2015-307774. doi: 10.1136/bjophthalmol-2015-307774. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27030281
  • Lavezzo MM, Sakata VM, Morita C, Rodriguez EE, Abdallah SF, da Silva FT, Hirata CE, Yamamoto JH.
    Vogt-Koyanagi-Harada disease: review of a rare autoimmune disease targeting antigens of melanocytes.
    Orphanet J Rare Dis. 2016 Mar 24;11(1):29. doi: 10.1186/s13023-016-0412-4.
    http://www.ncbi.nlm.nih.gov/pubmed/27008848
  • Nobre-Cardoso J, Champion E, Darugar A, Fel A, Lehoang P, Bodaghi B.
    Treatment of Non-infectious Uveitic Macular Edema with the Intravitreal Dexamethasone Implant.
    Ocul Immunol Inflamm. 2016 Mar 22:1-8. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/27003221

FEBRERO 2016
  • Henderson LA, Zurakowski D, Angeles-Han ST, Lasky A, Rabinovich CE, Lo MS; CARRA Registry Investigators.
    Medication use in juvenile uveitis patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance Registry.
    Pediatr Rheumatol Online J. 2016 Feb 16;14(1):9. doi: 10.1186/s12969-016-0069-5.
    http://www.ncbi.nlm.nih.gov/pubmed/26879972
  • Kolomeyer AM, Tu Y, Miserocchi E, Ranjan M, Davidow A, Chu DS.
    Chronic Non-infectious Uveitis in Patients with Juvenile Idiopathic Arthritis.
    Ocul Immunol Inflamm. 2016 Feb 22:1-9. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26902465
  • Haasnoot AJ, Kuiper JJ, Hiddingh S, Schellekens PA, de Jager W2, Imhof SM, Radstake TR, de Boer JH.
    Ocular fluid analysis in children reveals interleukin-29/interferon-λ1 as a biomarker for juvenile idiopathic arthritis associated uveitis.
    Arthritis Rheumatol. 2016 Feb 11. doi: 10.1002/art.39621. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26866822
  • Amin RM, Miserocchi E, Thorne JE, Hornbeak D, Jabs DA, Zierhut M.
    Treatment Options for Juvenile Idiopathic Arthritis (JIA) Associated Uveitis.
    Ocul Immunol Inflamm. 2016 Feb;24(1):81-90. doi: 10.3109/09273948.2015.1077976. Epub 2015 Dec 11.
    http://www.ncbi.nlm.nih.gov/pubmed/26652068
  • Grixti A, Hagan R, Nayak H, Chandna A.
    Multifocal choroiditis with panuveitis in an 8-year-old boy with long standing idiopathic acute anterior uveitis.
    Eur J Ophthalmol. 2016 Feb 29:0. doi: 10.5301/ejo.5000772. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26951535

ENERO 2016
  • Tappeiner C, Schenck S, Niewerth M, Heiligenhaus A, Minden K, Klotsche J.
    Impact of Antiinflammatory Treatment on the Onset of Uveitis in Juvenile Idiopathic Arthritis: Longitudinal Analysis From a Nationwide Pediatric Rheumatology Database.
    Arthritis Care Res (Hoboken). 2016 Jan;68(1):46-54. doi: 10.1002/acr.22649.
    http://onlinelibrary.wiley.com/doi/10.1002/acr.22649/abstract

DICIEMBRE 2015
  • Tappeiner C, Klotsche J, Schenck S, Niewerth M, Minden K, Heiligenhaus A.
    Temporal change in prevalence and complications of uveitis associated with juvenile idiopathic arthritis:data from a cross-sectional analysis of a prospective nationwide study.

    Clin Exp Rheumatol. 2015 Nov-Dec;33(6):936-44.
    http://www.ncbi.nlm.nih.gov/pubmed/26517055

NOVIEMBRE 2015
  • Sheila T. Angeles-Han, Steven Yeh, Courtney McCracken, Kirsten Jenkins, Daneka Stryker, Erica Myoung, Larry B. Vogler, Kelly Rouster-Stevens, Scott R. Lambert, Melanie J. Harrison, Sampath Prahalad and Carolyn Drews-Botsch
    Using the Effects of Youngsters’ Eyesight on Quality of Life Questionnaire to Measure Visual Outcomes in Children With Uveitis (pages 1513–1520)

    Arthritis Care & Research DOI: 10.1002/acr.22627
    Abstract
  • Ivan Foeldvari, Ingrid Becker and Gerd Horneff
    Uveitis Events During Adalimumab, Etanercept, and Methotrexate Therapy in Juvenile Idiopathic Arthritis: Data From the Biologics in Pediatric Rheumatology Registry (pages 1529–1535)
    Arthritis Care & Research
    DOI: 10.1002/acr.22613
    Abstract

OCTUBRE 2015
  • Haroon M, O'Rourke M, Ramasamy P, Murphy CC, FitzGerald O.
    A novel evidence-based detection of undiagnosed spondyloarthritis in patients presenting with acute anterior uveitis: the DUET (Dublin Uveitis Evaluation Tool)
    Ann Rheum Dis 2015;74:1990-5.
    http://ard.bmj.com/content/74/11/1990.abstract 
  • Gupta A, Ramanan AV
    Uveitis in Children: Diagnosis and Management.
    Indian J Pediatr. 2015 Sep 30. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26420255
  • Angeles-Han ST, McCracken C, Yeh S, Jang SR, Jenkins K, Cope S, Bohnsack J, Hersh A, Thompson SD, Prahalad S
    HLA Associations in a Cohort of Children With Juvenile Idiopathic Arthritis With and Without Uveitis
    Invest Ophthalmol Vis Sci. 2015 Sep 1;56(10):6043-8. doi: 10.1167/iovs.15-17168.
    http://www.ncbi.nlm.nih.gov/pubmed/26393471

SEPTIEMBRE 2015
  • Simonini G, Cimaz R, Jones GT, Macfarlane GJ.
    Non-anti-TNF biologic modifier drugs in non-infectious refractory chronic uveitis: The current evidence from a systematic review.
    Semin Arthritis Rheum. 2015 Oct;45(2):238-50. doi: 10.1016/j.semarthrit.2015.05.006
    http://www.ncbi.nlm.nih.gov/pubmed/26164255
  • Miserocchi E, Modorati G, Berchicci L, Pontikaki I, Meroni P, Gerloni V.
    Long-term treatment with rituximab in severe juvenile idiopathic arthritis-associated uveitis.
    Br J Ophthalmol. 2015 Sep 22. pii: bjophthalmol-2015-306790. doi: 10.1136/bjophthalmol-2015-306790. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26396026

AGOSTO 2015
  • Angeles-Han ST, McCracken C, Yeh S, Jenkins K, Stryker D, Travers C, Rouster-Stevens K, Vogler LB, Lambert SR, Drews-Botsch C, Prahalad S.
    The Association of Race with Childhood Uveitis.
    Am J Ophthalmol. 2015 Aug 6. pii:S0002-9394(15)00463-8. doi: 10.1016/j.ajo.2015.08.002. EPUB ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26255577  
  • Liang F, Terrada C, Ducos de Lahitte G, Quartier P, Lehoang P, Thorne JE, Bodaghi B.
    Foveal Serous Retinal Detachment in Juvenile Idiopathic Arthritis-associated Uveitis.
    Ocul Immunol Inflamm. 2015 Aug 19:1-6. EPUB ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26171661  
  • Marrani E, Paganelli V, de Libero C, Cimaz R, Simonini G.
    Long-term efficacy of abatacept in pediatric patients with idiopathic uveitis: a case series.
    Graefes Arch Clin Exp Ophthalmol. 2015 Aug 27. EPUB ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26311261  

JULIO 2015
  • Tappeiner C, Schenck S, Niewerth M, Heiligenhaus A, Minden K, Klotsche J
    Impact of anti-inflammatory treatment on the onset of uveitis in juvenile idiopathic arthritis: Longitudinal analysis from a nation-wide paediatric rheumatological database.
    Arthritis Care Res (Hoboken). 2015 Jul 20. doi: 10.1002/acr.22649. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/26212111

JUNIO 2015
  • de Groot-Mijnes JD, Dekkers J, de Visser L, Rothova A, van Loon AM, de Boer JH.
    Antibody Production against B19 Virus in Ocular Fluid of JIA-Associated Uveitis Patients.
    Ophthalmology. 2015 Jun;122(6):1270-1272.e1. doi: 10.1016/j.ophtha.2015.01.006.
    http://www.ncbi.nlm.nih.gov/pubmed/25704320
  •  Rosenbaum JT.
    Uveitis in spondyloarthritis including psoriatic arthritis, ankylosing spondylitis, and inflammatory bowel disease.
    Clin Rheumatol. 2015 Jun;34(6):999-1002. doi: 10.1007/s10067-015-2960-8.
    http://www.ncbi.nlm.nih.gov/pubmed/25953065
  •  Angeles-Han ST, McCracken C, Yeh S, Jenkins K, Stryker D, Rouster-Stevens K, Vogler LB, Lambert SR et al.
    Characteristics of a cohort of children with Juvenile Idiopathic Arthritis and JIA-associated Uveitis
    Pediatr Rheumatol Online J. 2015 Jun 2;13:19. doi: 10.1186/s12969-015-0018-8.
    http://www.ncbi.nlm.nih.gov/pubmed/26031738
  •  Sen ES, Dick AD, Ramanan AV.
    Uveitis associated with juvenile idiopathic arthritis.
    Nat Rev Rheumatol. 2015 Jun;11(6):338-348. doi: 10.1038/nrrheum.2015.20.
    http://www.ncbi.nlm.nih.gov/pubmed/25825278

MAYO 2015

ABRIL 2015
  • Klotsche J, Niewerth M, Haas JP, Huppertz HI, Zink A, Horneff G, Minden K.
    Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA).
    Ann Rheum Dis. 2015 Apr 29. pii: annrheumdis-2014-206747. doi: 10.1136/annrheumdis-annrheumdis-2014-206747. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25926155  
  • Lerman MA, Rabinovich CE.
    The Future Is Now: Biologics for Non-Infectious Pediatric Anterior Uveitis.

    Paediatr Drugs. 2015 Apr 17. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25893479

MARZO 2015
  • Sen ES, Dick AD, Ramanan AV.
    Uveitis associated with juvenile idiopathic arthritis.
    Nat Rev Rheumatol. 2015 Mar 31. doi: 10.1038/nrrheum.2015.20. [Epub ahead of print] Review.
    http://www.ncbi.nlm.nih.gov/pubmed/25825278

FEBRERO 2015
  • Heiligenhaus, A; Minden, K; Föll, D; Pleyer, U
    Uveitis in juvenile idiopathic arthritis.
    Dtsch Arztebl Int. 2015 Feb 6;112(6):92-100.
    http://www.ncbi.nlm.nih.gov/pubmed/25721436
  • Bou R, Adán A, Borrás F, Bravo B, Calvo I, De Inocencio J, Díaz J, Escudero J, Fonollosa A, de Vicuña CG, Hernández V, Merino R, Peralta J, Rúa MJ, Tejada P, Antón J.
    Clinical management algorithm of uveitis associated with juvenile idiopathic arthritis: interdisciplinary panel consensus.
    Rheumatol Int. 2015 Feb 6.
    http://www.ncbi.nlm.nih.gov/pubmed/25656443
  • Tappeiner C, Miserocchi E, Bodaghi B, Kotaniemi K, Mackensen F, Gerloni V, Quartier P, Lutz T, Heiligenhaus A.
    Abatacept in the Treatment of Severe, Longstanding, and Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.
    J Rheumatol. 2015 Feb 1.
    http://www.ncbi.nlm.nih.gov/pubmed/25641892
  • Haasnoot AJ, van Tent-Hoeve M, Wulffraat NM, Schalij-Delfos NE, Los LI, Armbrust W, Zuithoff NP, de Boer JH.
    Erythrocyte sedimentation rate as baseline predictor for the development of uveitis in children with juvenile idiopathic arthritis.
    Am J Ophthalmol. 2015 Feb;159(2):372-7.
    http://www.ncbi.nlm.nih.gov/pubmed/25447121

ENERO 2015
  • Christoph Tappeiner, Elisabetta Miserocchi, Bahram Bodaghi, Kaisu Kotaniemi, Friederike Mackensen, Valeria Gerloni, Pierre Quartier, Thomas Lutz and Arnd Heiligenhaus
    Abatacept in the Treatment of Severe, Longstanding, and Refractory Uveitis Associated with Juvenile Idiopathic Arthritis
    J Rheumatol published online before print February 1, 2015,doi:10.3899/jrheum.140410
    http://www.jrheum.org/content/early/2015/01/27/jrheum.140410.abstract

DICIEMBRE 2014

NOVIEMBRE 2014
  • Hettinga YM, Verhagen FH, van Genderen M, de Boer JH.
    Characteristics of childhood uveitis leading to visual impairment and blindness in the Netherlands.
    Acta Ophthalmol. 2014 Dec;92(8):798-804.
    http://www.ncbi.nlm.nih.gov/pubmed/?term=24975684

OCTUBRE 2014
  • Langner-Wegscheider BJ, de Smet MD
    Surgical Management of Severe Complications Arising from Uveitis in Juvenile Idiopathic Arthritis
    Ophthalmologica. 2014 Oct 18. [Epub ahead of print]

SEPTIEMBRE 2014
  • Kalinina Ayuso V, Makhotkina N, van Tent-Hoeve M, de Groot-Mijnes JD, Wulffraat NM, Rothova A, de Boer JH.
    Pathogenesis of juvenile idiopathic arthritis associated uveitis: the known and unknown.
    Surv Ophthalmol. 2014 September - October;59(5):517-531.
    http://www.ncbi.nlm.nih.gov/pubmed/25130893

AGOSTO 2014

JULIO 2014
  • Interlandi E, Leccese P, Olivieri I, Latanza L.
    Adalimumab for treatment of severe Behçet's uveitis: a retrospective long-term follow-up study.
    Clin Exp Rheumatol. 2014 Jul 8. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/25005224
  • Vastert SJ1, Bhat P, Goldstein DA.
    Pathophysiology of JIA-associated Uveitis.
    Ocul Immunol Inflamm. 2014 Jul 2:1-10. 
    http://www.ncbi.nlm.nih.gov/pubmed/24988139
  • Simonini G1, Katie D, Cimaz R, Macfarlane GJ, Jones GT.
    Current Evidence of Anti-TNFα treatment efficacy in childhood chronic uveitis: A systematic review and meta-analysis approach of individual drugs.
    Arthritis Care Res (Hoboken). 2014 July;66(7):1073-84 doi: 10.1002/acr.22214.
    http://www.ncbi.nlm.nih.gov/pubmed/24740981
  • Calandra S1, Gallo MC1, Consolaro A1, Pistorio A1, Lattanzi B1, Bovis F1, Muratore V1, De Marco R1, Martini A1, Ravelli A2.
    Female sex and oligoarthritis category are not risk factors for uveitis in italian children with juvenile idiopathic arthritis.
    J Rheumatol. 2014 Jul;41(7):1416-25. doi: 10.3899/jrheum.131494. Epub 2014 Jun 15.
    http://www.ncbi.nlm.nih.gov/pubmed/24931957

JUNIO 2014

MAYO 2014
  • Totan Y, Güler E, Guragaç FB, Dervisogullari MS, Tenlik A, Hepsen IF.
    Cystoid macular edema associated with juvenile idiopathic arthritis resolved by a dexamethasone intravitreal implant.
    J Pediatr Ophthalmol Strabismus. 2014 May 6;51:e25-8. doi: 10.3928/01913913-20140429-01.
    http://www.ncbi.nlm.nih.gov/pubmed/24811080

ABRIL 2014
  • Emmi G, Silvestri E, Ciucciarelli L, Squatrito D, Emmi L.
    Anti-IL1 blocking agents in drug-resistant Behçet's syndrome: our little case series.
    Clin Exp Rheumatol. 2014 Apr 7. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24709082

FEBRERO 2014
  • Pasadhika S, Rosenbaum JT.
    Update on the use of systemic biologic agents in the treatment of noninfectious uveitis.
    Biologics. 2014 Feb 15;8:67-81.
    http://www.ncbi.nlm.nih.gov/pubmed/24600203
  • Tugal-Tutkun 1, Quartier P, Bodaghi B.
    Disease of the Year: Juvenile Idiopathic Arthritis-associated Uveitis-Classification and Diagnostic Approach.
    Ocul Immunol Inflamm. 2014 Feb;22(1):56-63. doi: 10.3109/09273948.2013.871565. Epub 2014 Jan 10.
    http://www.ncbi.nlm.nih.gov/pubmed/24410427
  • Pålsson S, Nyström A, Sjödell L, Jakobsson G, Byhr E, Andersson Grönlund M, Zetterberg M.
    Combined Phacoemulsification, Primary Intraocular Lens Implantation, and Pars Plana Vitrectomy in Children with Uveitis.
    Ocul Immunol Inflamm. 2014 Feb 24. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24564567
  • Angeles-Han ST, Yeh S, Vogler LB.
    Updates on the risk markers and outcomes of severe juvenile idiopathic arthritis-associated uveitis.
    Int J Clin Rheumtol. 2013 Feb 1;8(1). doi: 10.2217/ijr.12.83.
    http://www.ncbi.nlm.nih.gov/pubmed/24187594

ENERO 2014
  • de Boer J, Steijaert A, van den Bor R, Stellato R, Ossewaarde-van Norel J.
    Development of Macular Edema and Impact on Visual Acuity in Uveitis Associated with Juvenile Idiopathic Arthritis.
    Ocul Immunol Inflamm. 2014 Jan 10. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24410459

DICIEMBRE 2013
  • Levy-Clarke G, Jabs DA, Read RW, Rosenbaum JT, Vitale A, Van Gelder RN.
    Expert Panel Recommendations for the Use of Anti-Tumor Necrosis Factor Biologic Agents in Patients with Ocular Inflammatory Disorders.
    Ophthalmology. 2013 Dec 17. pii: S0161-6420(13)00893-2. doi: 10.1016/j.ophtha.2013.09.048. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24359625
  • Kotaniemi K, Sihto-Kauppi K, Salomaa P, Säilä H, Ristolainen L, Kauppi M.
    The frequency and outcome of uveitis in patients with newly diagnosed juvenile idiopathic arthritis in two 4-year cohorts from 1990-1993 and 2000-2003.
    Clin Exp Rheumatol. 2013 Dec 16. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24351424
  • Artornsombudh P, Pistilli M, Foster CS, Pujari SS, Gangaputra SS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Suhler EB, Thorne JE, Kempen JH.
    Factors Predictive of Remission of New-Onset Anterior Uveitis.
    Ophthalmology. 2013 Dec 14. pii: S0161-6420(13)00886-5. doi: 10.1016/j.ophtha.2013.09.041. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/24342020
  • Angeles-Han ST, Pelajo CF, Vogler LB, Rouster-Stevens K, Kennedy C, Ponder L, McCracken C, Lopez-Benitez J, Drews-Botsch C, Prahalad S; CARRA Registry Investigators.
    Risk Markers of Juvenile Idiopathic Arthritis-associated Uveitis in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry.
    J Rheumatol. 2013 Dec;40(12):2088-96. doi: 10.3899/jrheum.130302. Epub 2013 Nov 1.
    http://www.ncbi.nlm.nih.gov/pubmed/24187099

OCTUBRE 2013

AGOSTO 2013
  • Lerman MA, Burnham JM, Chang PY, Daniel E, Foster CS, Hennessy S, Jabs DA, Joffe MM, Oktay Kaçmaz R, Levy-Clarke GA, Mills MD, Nussenblatt RB,Rosenbaum JT, Suhler EB, Thorne JE, Kempen JH.
    Response of Pediatric Uveitis to Tumor Necrosis Factor-a Inhibitors.
    J Rheumatol. 2013 Aug;40(8):1394-1403.

JUNIO 2013
  • Zierhut M, Heiligenhaus A, deBoer J, Cunningham ET, Tugal-Tutkun I.
    Controversies in juvenile idiopathic arthritis-associated uveitis.
    Ocul Immunol Inflamm. 2013 Jun;21(3):167-79. doi: 10.3109/09273948.2013.800561.
    http://www.ncbi.nlm.nih.gov/pubmed/23713826

MAYO 2013
  • Papadopoulou C, Kostik M, Böhm M, Nieto-Gonzalez JC, Gonzalez-Fernandez MI, Pistorio A, Martini A, Ravelli A.
    Methotrexate Therapy May Prevent the Onset of Uveitis in Juvenile Idiopathic Arthritis.
    J Pediatr 2013 May 9. pii: S0022-3476(13)00323-5. doi: 10.1016/j.jpeds.2013.03.047. [Epub ahead of print]
    http://www.ncbi.nlm.nih.gov/pubmed/23664559
  • Simonini G, Paudyal P, Jones GT, Cimaz R,Macfarlane GJ.
    Current evidence of methotrexate efficacy in childhood chronic uveitis: a systematic review and meta-analysis approach.
    Rheumatology 2013 May; 52:825-31.
    http://www.ncbi.nlm.nih.gov/pubmed/22879466
  • Sakai T, Watanabe H, Kuroyanagi K, Akiyama G, Okano K, Kohno H, Tsuneoka H.
    Health- and vision-related quality of life in patients receiving infliximab therapy for Behcet uveitis.
    Br J Ophthalmol. 2013; 97:338-42.
    http://www.ncbi.nlm.nih.gov/pubmed/23314623

ENERO 2013
  • Zannin ME, Birolo C, Gerloni VM, Miserocchi E, et al.
    Safety and Efficacy of Infliximab and Adalimumab for Refractory Uveitis in Juvenile Idiopathic Arthritis: 1-year Followup Data from the Italian Registry.
    J Rheumatol. 2013 Jan;40(1):74-9. doi: 10.3899/jrheum.120583.

OCTUBRE 2012
  • Gregory AC 2nd,Kempen JH,Daniel E et al.
    Risk Factors for Loss of Visual Acuity among Patients with Uveitis Associated with Juvenile Idiopathic Arthritis: The Systemic Immunosuppressive Therapy for Eye Diseases Study.
    Ophthalmology.2012 Oct 11. pii: S0161-6420(12)00687-2. doi: 10.1016/j.ophtha.2012.07.052. [Epub ahead of print].
    http://www.ncbi.nlm.nih.gov/pubmed/23062650

SEPTIEMBRE 2012
  • Heiligenhaus A, Foeldvari I, Edelsten C, Smith JR, Saurenmann RK, Bodaghi B, de Boer J, Graham E, Anton J, Kotaniemi K, Mackensen F, Minden K, Nielsen S, Rabinovich EC, Ramanan AV, Strand V; Multinational Interdisciplinary Working Group for Uveitis in Childhood.
    Proposed outcome measures for prospective clinical trials in juvenile idiopathic arthritis-associated uveitis: a consensus effort from the multinational interdisciplinary working group for uveitis in childhood.
    Arthritis Care Res (Hoboken). 2012 Sep;64(9):1365-72. doi: 10.1002/acr.21674.
    http://www.ncbi.nlm.nih.gov/pubmed/22438273

JUNIO 2012
  • Tappeiner C, Heinz C, Ganser G, Heiligenhaus A
    Is tocilizumab an effective option for treatment of refractory uveitis associated with juvenile idiopathic arthritis?
    J Rheumatol. 2012 Jun;39(6):1294-5
    http://www.ncbi.nlm.nih.gov/pubmed/22661419
PATROCINADORES

Área de Socios